federal_register: E9-30750
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E9-30750 | Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions." This guidance describes the circumstances in which FDA will not object to certain compounding of Tamiflu Oral Suspension in advance of receiving prescriptions. | 2009-12-29 | 2009 | 12 | https://www.federalregister.gov/documents/2009/12/29/E9-30750/guidance-to-pharmacies-on-advance-compounding-of-tamiflu-oral-suspension-to-provide-for-multiple | https://www.govinfo.gov/content/pkg/FR-2009-12-29/pdf/E9-30750.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions." This guidance describes the... |